AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-5.88 Cr | ₹0.65 Cr | ₹-1.97 Cr | ₹-2.64 Cr | ₹1.95 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-5.88 Cr |
| Mar2024 | ₹0.65 Cr |
| Mar2023 | ₹-1.97 Cr |
| Mar2022 | ₹-2.64 Cr |
| Mar2021 | ₹1.95 Cr |
How is Net Cash Inflow / Outflow of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5.88 Cr | Negative | |
| Mar2024 | ₹0.65 Cr | Positive | |
| Mar2023 | ₹-1.97 Cr | Negative | |
| Mar2022 | ₹-2.64 Cr | Negative | |
| Mar2021 | ₹1.95 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹219.2 Cr | 14.5% | 0.1% | -23.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 14.5% |
0.1% |
-23.4% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses